BLRX TLV Week ended 31 Jul 2026

Weekly Investor Report

Name: BLRX weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

BioLineRx Ltd. · Healthcare · Biotechnology

Open interactive chart View report data

Latest close 0.02 ILA

6.7% latest week

Weekly setup

Constructive, but selective

The weekly trend is active. Price is 9.1% above the Trend Line and sits at 38.5% of its 52-week range. The latest completed week returned 6.7%, after a 6.7% four-week move. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.

Setup score 28 out of 100

Latest Close 0.02 ILA 31 Jul 2026

1W Return 6.7% latest completed week

4W Return 6.7% short-term follow-through

12W Return 0.0% quarterly tape

Trend Breadth 3.8% 2 of 52 weeks active

Volume Ratio 0.2x vs 13-week average

What is working

The trend backdrop is active with a 2-week active streak.
Price is above the Trend Line, keeping the weekly tape constructive.
Activity pressure is positive on the latest completed week.
Latest weekly return ranks in the strongest part of its sector group.

What could go wrong

Price is below Fair Value, so the market is still discounting the latest tape.
Next-week expectancy is negative at 27.21% based on similar historical setup states.
Activity pressure is weak, so confirmation is not yet broad enough.
The share remains more than 20% below its 52-week high.

What to watch next

Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through 6.7% Latest completed week; four-week move 6.7%. Indicator stack 9/69 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 27.21% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 53/100 10 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 9.1% above the Trend Line and sits at 38.5% of its 52-week range. The latest completed week returned 6.7%, after a 6.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

0.01 ILA 38.5% 0.02 ILA

Range location38.5%Shows where the latest close sits between the 52-week low and high.

Trend distance9.1%Price premium or discount versus the weekly Trend Line.

Fair-value gap-87.6%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-33.3%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1712-week average 0.20

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.17Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 6.7% over four weeks, 0.0% over 12 weeks, and -30.4% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W6.7%

4W6.7%

12W0.0%

26W6.7%

52W-30.4%

Active trend streak2 weeks

Active weeks in one year2

Trend breadth3.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure1.11Latest activity-pressure read.

Pressure change-16.8%Four-week change in activity pressure.

Leadership-16.18Latest relative-leadership reading.

RS change39.0%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 10 relevant articles.

2 positive · 8 neutral · 0 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-33.3%Distance below the 52-week high.

13-week volatility9.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

6 Feb 6 Mar 3 Apr 1 May 29 May 26 Jun 31 Jul

Weeks higher6 of 267 weeks finished lower.

Best week+23.1%Week of 29 May.

Worst week-12.5%Week of 15 May.

Latest week+6.7%Week of 31 Jul.

Shape of recent returns

Strong gains6

Modest gains0

Flat weeks13

Modest losses0

Sharp losses7

Recent vol9.2%13-week weekly-return volatility.

Base vol6.3%52-week weekly-return volatility.

Up/down split10/17Count of positive and negative weeks in the 52-week window.

Average skew9.4% / -7.0%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorIL Healthcare

4-week rank6 / 50

Group average-6.0%

Trend breadth6.0%

Trend6.0%active weekly trend signals

MD18.0%positive activity pressure

RS4.0%positive relative leadership

Four-week leaders

EVGN · TLV18.5%MRHL · TLV9.3%IDNT · TLV8.5%NVLG · TLV7.8%SEMG · TLV7.1%

IndustryIL Biotechnology

4-week rank2 / 14

Group average-5.6%

Trend breadth14.3%

Trend14.3%active weekly trend signals

MD28.6%positive activity pressure

RS7.1%positive relative leadership

Four-week leaders

EVGN · TLV18.5%BLRX · TLV6.7%XTLB · TLV5.3%CGEN · TLV1.1%PPBT · TLV0.0%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape23/100

Trend, activity pressure, participation, and risk combine to a 23/100 tape read.

Indicator analysis37/100

Latest 12-week confirmation: trend 2/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.17; No reversal markers Next-Week ExpectancyNegative 27.21%

Next-week expectancy is negative with a 27.21% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 10 relevant articles.

Price to sales forward of BioLineRX Ltd. – TASE:BLRX Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
31 Jul 2026	0.02 ILA	6.7%	0.01 ILA	0.13 ILA	1.11	-16.18	3.3M	On
24 Jul 2026	0.01 ILA	7.1%	0.01 ILA	0.13 ILA	1.13	-24.52	5.2M	On
17 Jul 2026	0.01 ILA	-6.7%	0.01 ILA	0.13 ILA	1.19	-29.01	9.0M	Off
10 Jul 2026	0.01 ILA	0.0%	0.01 ILA	0.14 ILA	1.37	-23.86	41.2M	Off
3 Jul 2026	0.01 ILA	0.0%	0.01 ILA	0.14 ILA	1.34	-26.53	7.2M	Off
26 Jun 2026	0.01 ILA	-6.3%	0.01 ILA	0.14 ILA	1.42	-26.11	0	Off
19 Jun 2026	0.02 ILA	0.0%	0.02 ILA	0.14 ILA	1.60	-24.78	444.7K	Off
12 Jun 2026	0.02 ILA	0.0%	0.02 ILA	0.15 ILA	1.61	-29.73	2.5M	Off
5 Jun 2026	0.02 ILA	0.0%	0.02 ILA	0.15 ILA	1.50	-30.38	15.4M	Off
29 May 2026	0.02 ILA	23.1%	0.02 ILA	0.15 ILA	1.61	-34.75	44.8M	Off
22 May 2026	0.01 ILA	-7.1%	0.02 ILA	0.15 ILA	1.58	-47.07	65.9M	Off
15 May 2026	0.01 ILA	-12.5%	0.02 ILA	0.16 ILA	1.33	-43.95	33.1M	Off
8 May 2026	0.02 ILA	14.3%	0.02 ILA	0.16 ILA	1.05	-38.62	52.0M	Off
1 May 2026	0.01 ILA	7.7%	0.02 ILA	0.16 ILA	0.77	-45.87	70.0M	Off

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.